nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—CYP2D6—Temsirolimus—kidney cancer	0.104	0.372	CbGbCtD
Zuclopenthixol—CYP2D6—Pazopanib—kidney cancer	0.0544	0.195	CbGbCtD
Zuclopenthixol—CYP2D6—Erlotinib—kidney cancer	0.0388	0.139	CbGbCtD
Zuclopenthixol—CYP2D6—Sorafenib—kidney cancer	0.0316	0.113	CbGbCtD
Zuclopenthixol—CYP2D6—Vinblastine—kidney cancer	0.0312	0.112	CbGbCtD
Zuclopenthixol—CYP2D6—Doxorubicin—kidney cancer	0.0191	0.0687	CbGbCtD
Zuclopenthixol—Flupentixol—ABCB1—kidney cancer	0.000618	0.168	CrCbGaD
Zuclopenthixol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000455	0.000634	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Vincristine—kidney cancer	0.000455	0.000633	CcSEcCtD
Zuclopenthixol—Fatigue—Vincristine—kidney cancer	0.000454	0.000633	CcSEcCtD
Zuclopenthixol—Rash—Erlotinib—kidney cancer	0.000453	0.000632	CcSEcCtD
Zuclopenthixol—Dermatitis—Erlotinib—kidney cancer	0.000453	0.000631	CcSEcCtD
Zuclopenthixol—Palpitations—Paclitaxel—kidney cancer	0.000453	0.000631	CcSEcCtD
Zuclopenthixol—Insomnia—Gemcitabine—kidney cancer	0.000452	0.00063	CcSEcCtD
Zuclopenthixol—Eye disorder—Capecitabine—kidney cancer	0.000451	0.000629	CcSEcCtD
Zuclopenthixol—Headache—Erlotinib—kidney cancer	0.000451	0.000628	CcSEcCtD
Zuclopenthixol—Tinnitus—Capecitabine—kidney cancer	0.00045	0.000628	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Paclitaxel—kidney cancer	0.00045	0.000628	CcSEcCtD
Zuclopenthixol—Pain—Vincristine—kidney cancer	0.00045	0.000627	CcSEcCtD
Zuclopenthixol—Constipation—Vincristine—kidney cancer	0.00045	0.000627	CcSEcCtD
Zuclopenthixol—Paraesthesia—Gemcitabine—kidney cancer	0.000449	0.000625	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Capecitabine—kidney cancer	0.000448	0.000625	CcSEcCtD
Zuclopenthixol—Asthenia—Sunitinib—kidney cancer	0.000447	0.000622	CcSEcCtD
Zuclopenthixol—Dyspnoea—Gemcitabine—kidney cancer	0.000445	0.000621	CcSEcCtD
Zuclopenthixol—Nausea—Vinblastine—kidney cancer	0.000444	0.000619	CcSEcCtD
Zuclopenthixol—Somnolence—Gemcitabine—kidney cancer	0.000444	0.000619	CcSEcCtD
Zuclopenthixol—Convulsion—Paclitaxel—kidney cancer	0.000444	0.000619	CcSEcCtD
Zuclopenthixol—Migraine—Doxorubicin—kidney cancer	0.000443	0.000617	CcSEcCtD
Zuclopenthixol—Nausea—Everolimus—kidney cancer	0.000443	0.000617	CcSEcCtD
Zuclopenthixol—Diarrhoea—Sorafenib—kidney cancer	0.000443	0.000617	CcSEcCtD
Zuclopenthixol—Hypertension—Paclitaxel—kidney cancer	0.000442	0.000616	CcSEcCtD
Zuclopenthixol—Pruritus—Sunitinib—kidney cancer	0.00044	0.000614	CcSEcCtD
Zuclopenthixol—Angiopathy—Capecitabine—kidney cancer	0.000438	0.000611	CcSEcCtD
Zuclopenthixol—Immune system disorder—Capecitabine—kidney cancer	0.000436	0.000608	CcSEcCtD
Zuclopenthixol—Myalgia—Paclitaxel—kidney cancer	0.000436	0.000608	CcSEcCtD
Zuclopenthixol—Anxiety—Paclitaxel—kidney cancer	0.000435	0.000606	CcSEcCtD
Zuclopenthixol—Decreased appetite—Gemcitabine—kidney cancer	0.000434	0.000605	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Dactinomycin—kidney cancer	0.000434	0.000605	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000433	0.000604	CcSEcCtD
Zuclopenthixol—Arrhythmia—Capecitabine—kidney cancer	0.000432	0.000601	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000431	0.000601	CcSEcCtD
Zuclopenthixol—Discomfort—Paclitaxel—kidney cancer	0.000431	0.000601	CcSEcCtD
Zuclopenthixol—Fatigue—Gemcitabine—kidney cancer	0.000431	0.0006	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Vincristine—kidney cancer	0.000431	0.0006	CcSEcCtD
Zuclopenthixol—Dizziness—Sorafenib—kidney cancer	0.000428	0.000596	CcSEcCtD
Zuclopenthixol—Pain—Gemcitabine—kidney cancer	0.000427	0.000595	CcSEcCtD
Zuclopenthixol—Constipation—Gemcitabine—kidney cancer	0.000427	0.000595	CcSEcCtD
Zuclopenthixol—Nausea—Erlotinib—kidney cancer	0.000427	0.000595	CcSEcCtD
Zuclopenthixol—Dry mouth—Paclitaxel—kidney cancer	0.000427	0.000594	CcSEcCtD
Zuclopenthixol—Diarrhoea—Sunitinib—kidney cancer	0.000426	0.000593	CcSEcCtD
Zuclopenthixol—Ataxia—Doxorubicin—kidney cancer	0.000423	0.00059	CcSEcCtD
Zuclopenthixol—Mental disorder—Capecitabine—kidney cancer	0.000423	0.00059	CcSEcCtD
Zuclopenthixol—Asthenia—Dactinomycin—kidney cancer	0.000423	0.000589	CcSEcCtD
Zuclopenthixol—Malnutrition—Capecitabine—kidney cancer	0.000421	0.000586	CcSEcCtD
Zuclopenthixol—Erythema—Capecitabine—kidney cancer	0.000421	0.000586	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Paclitaxel—kidney cancer	0.000418	0.000583	CcSEcCtD
Zuclopenthixol—Body temperature increased—Vincristine—kidney cancer	0.000416	0.00058	CcSEcCtD
Zuclopenthixol—Abdominal pain—Vincristine—kidney cancer	0.000416	0.00058	CcSEcCtD
Zuclopenthixol—Domperidone—ABCB1—kidney cancer	0.000416	0.113	CrCbGaD
Zuclopenthixol—Liver function test abnormal—Doxorubicin—kidney cancer	0.000416	0.000579	CcSEcCtD
Zuclopenthixol—Chlorpromazine—BCHE—kidney cancer	0.000415	0.113	CrCbGaD
Zuclopenthixol—Flatulence—Capecitabine—kidney cancer	0.000414	0.000577	CcSEcCtD
Zuclopenthixol—Dizziness—Sunitinib—kidney cancer	0.000412	0.000574	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Gemcitabine—kidney cancer	0.000412	0.000574	CcSEcCtD
Zuclopenthixol—Shock—Paclitaxel—kidney cancer	0.000411	0.000573	CcSEcCtD
Zuclopenthixol—Vomiting—Sorafenib—kidney cancer	0.000411	0.000573	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Paclitaxel—kidney cancer	0.00041	0.000571	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Paclitaxel—kidney cancer	0.000409	0.000571	CcSEcCtD
Zuclopenthixol—Tachycardia—Paclitaxel—kidney cancer	0.000408	0.000569	CcSEcCtD
Zuclopenthixol—Rash—Sorafenib—kidney cancer	0.000408	0.000568	CcSEcCtD
Zuclopenthixol—Dermatitis—Sorafenib—kidney cancer	0.000408	0.000568	CcSEcCtD
Zuclopenthixol—Breast disorder—Doxorubicin—kidney cancer	0.000407	0.000567	CcSEcCtD
Zuclopenthixol—Skin disorder—Paclitaxel—kidney cancer	0.000406	0.000566	CcSEcCtD
Zuclopenthixol—Headache—Sorafenib—kidney cancer	0.000405	0.000565	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Paclitaxel—kidney cancer	0.000404	0.000563	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dactinomycin—kidney cancer	0.000403	0.000562	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Doxorubicin—kidney cancer	0.000403	0.000561	CcSEcCtD
Zuclopenthixol—Anorexia—Paclitaxel—kidney cancer	0.000399	0.000555	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000397	0.000553	CcSEcCtD
Zuclopenthixol—Vision blurred—Capecitabine—kidney cancer	0.000396	0.000552	CcSEcCtD
Zuclopenthixol—Vomiting—Sunitinib—kidney cancer	0.000396	0.000552	CcSEcCtD
Zuclopenthixol—Body temperature increased—Gemcitabine—kidney cancer	0.000395	0.00055	CcSEcCtD
Zuclopenthixol—Tremor—Capecitabine—kidney cancer	0.000394	0.000549	CcSEcCtD
Zuclopenthixol—Rash—Sunitinib—kidney cancer	0.000393	0.000547	CcSEcCtD
Zuclopenthixol—Dermatitis—Sunitinib—kidney cancer	0.000392	0.000546	CcSEcCtD
Zuclopenthixol—Hypotension—Paclitaxel—kidney cancer	0.000391	0.000545	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Capecitabine—kidney cancer	0.00039	0.000544	CcSEcCtD
Zuclopenthixol—Headache—Sunitinib—kidney cancer	0.00039	0.000543	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Vincristine—kidney cancer	0.000388	0.000541	CcSEcCtD
Zuclopenthixol—Eosinophilia—Doxorubicin—kidney cancer	0.000385	0.000537	CcSEcCtD
Zuclopenthixol—Nausea—Sorafenib—kidney cancer	0.000384	0.000535	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000381	0.000531	CcSEcCtD
Zuclopenthixol—Malaise—Capecitabine—kidney cancer	0.000379	0.000528	CcSEcCtD
Zuclopenthixol—Insomnia—Paclitaxel—kidney cancer	0.000378	0.000527	CcSEcCtD
Zuclopenthixol—Vertigo—Capecitabine—kidney cancer	0.000378	0.000526	CcSEcCtD
Zuclopenthixol—Asthenia—Vincristine—kidney cancer	0.000378	0.000526	CcSEcCtD
Zuclopenthixol—Syncope—Capecitabine—kidney cancer	0.000377	0.000525	CcSEcCtD
Zuclopenthixol—Leukopenia—Capecitabine—kidney cancer	0.000376	0.000524	CcSEcCtD
Zuclopenthixol—Paraesthesia—Paclitaxel—kidney cancer	0.000376	0.000523	CcSEcCtD
Zuclopenthixol—Vomiting—Dactinomycin—kidney cancer	0.000375	0.000522	CcSEcCtD
Zuclopenthixol—Dyspnoea—Paclitaxel—kidney cancer	0.000373	0.00052	CcSEcCtD
Zuclopenthixol—Somnolence—Paclitaxel—kidney cancer	0.000372	0.000518	CcSEcCtD
Zuclopenthixol—Palpitations—Capecitabine—kidney cancer	0.000372	0.000518	CcSEcCtD
Zuclopenthixol—Rash—Dactinomycin—kidney cancer	0.000372	0.000518	CcSEcCtD
Zuclopenthixol—Nausea—Sunitinib—kidney cancer	0.00037	0.000515	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Capecitabine—kidney cancer	0.00037	0.000515	CcSEcCtD
Zuclopenthixol—Pancytopenia—Doxorubicin—kidney cancer	0.000369	0.000515	CcSEcCtD
Zuclopenthixol—Dyspepsia—Paclitaxel—kidney cancer	0.000368	0.000513	CcSEcCtD
Zuclopenthixol—Neutropenia—Doxorubicin—kidney cancer	0.000364	0.000507	CcSEcCtD
Zuclopenthixol—Dysuria—Doxorubicin—kidney cancer	0.000364	0.000507	CcSEcCtD
Zuclopenthixol—Decreased appetite—Paclitaxel—kidney cancer	0.000364	0.000507	CcSEcCtD
Zuclopenthixol—Hypertension—Capecitabine—kidney cancer	0.000363	0.000506	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000361	0.000503	CcSEcCtD
Zuclopenthixol—Fatigue—Paclitaxel—kidney cancer	0.000361	0.000502	CcSEcCtD
Zuclopenthixol—Diarrhoea—Vincristine—kidney cancer	0.00036	0.000502	CcSEcCtD
Zuclopenthixol—Asthenia—Gemcitabine—kidney cancer	0.000358	0.000499	CcSEcCtD
Zuclopenthixol—Myalgia—Capecitabine—kidney cancer	0.000358	0.000499	CcSEcCtD
Zuclopenthixol—Pain—Paclitaxel—kidney cancer	0.000358	0.000498	CcSEcCtD
Zuclopenthixol—Constipation—Paclitaxel—kidney cancer	0.000358	0.000498	CcSEcCtD
Zuclopenthixol—Anxiety—Capecitabine—kidney cancer	0.000357	0.000497	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000356	0.000495	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000355	0.000495	CcSEcCtD
Zuclopenthixol—Weight increased—Doxorubicin—kidney cancer	0.000354	0.000493	CcSEcCtD
Zuclopenthixol—Discomfort—Capecitabine—kidney cancer	0.000354	0.000493	CcSEcCtD
Zuclopenthixol—Pruritus—Gemcitabine—kidney cancer	0.000353	0.000492	CcSEcCtD
Zuclopenthixol—Weight decreased—Doxorubicin—kidney cancer	0.000352	0.00049	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Doxorubicin—kidney cancer	0.000351	0.000489	CcSEcCtD
Zuclopenthixol—Dry mouth—Capecitabine—kidney cancer	0.00035	0.000488	CcSEcCtD
Zuclopenthixol—Nausea—Dactinomycin—kidney cancer	0.00035	0.000488	CcSEcCtD
Zuclopenthixol—Dizziness—Vincristine—kidney cancer	0.000348	0.000485	CcSEcCtD
Zuclopenthixol—Drowsiness—Doxorubicin—kidney cancer	0.000347	0.000483	CcSEcCtD
Zuclopenthixol—Nefazodone—ABCB1—kidney cancer	0.000346	0.094	CrCbGaD
Zuclopenthixol—Feeling abnormal—Paclitaxel—kidney cancer	0.000345	0.00048	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000342	0.000477	CcSEcCtD
Zuclopenthixol—Diarrhoea—Gemcitabine—kidney cancer	0.000342	0.000476	CcSEcCtD
Zuclopenthixol—Jaundice—Doxorubicin—kidney cancer	0.000338	0.000471	CcSEcCtD
Zuclopenthixol—Shock—Capecitabine—kidney cancer	0.000338	0.00047	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Capecitabine—kidney cancer	0.000337	0.000469	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Capecitabine—kidney cancer	0.000336	0.000468	CcSEcCtD
Zuclopenthixol—Tachycardia—Capecitabine—kidney cancer	0.000335	0.000467	CcSEcCtD
Zuclopenthixol—Vomiting—Vincristine—kidney cancer	0.000335	0.000466	CcSEcCtD
Zuclopenthixol—Skin disorder—Capecitabine—kidney cancer	0.000333	0.000464	CcSEcCtD
Zuclopenthixol—Sweating—Doxorubicin—kidney cancer	0.000333	0.000463	CcSEcCtD
Zuclopenthixol—Rash—Vincristine—kidney cancer	0.000332	0.000463	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Capecitabine—kidney cancer	0.000332	0.000462	CcSEcCtD
Zuclopenthixol—Dermatitis—Vincristine—kidney cancer	0.000332	0.000462	CcSEcCtD
Zuclopenthixol—Body temperature increased—Paclitaxel—kidney cancer	0.000331	0.000461	CcSEcCtD
Zuclopenthixol—Abdominal pain—Paclitaxel—kidney cancer	0.000331	0.000461	CcSEcCtD
Zuclopenthixol—Headache—Vincristine—kidney cancer	0.00033	0.00046	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000328	0.000457	CcSEcCtD
Zuclopenthixol—Anorexia—Capecitabine—kidney cancer	0.000327	0.000456	CcSEcCtD
Zuclopenthixol—Clozapine—CYP1A1—kidney cancer	0.000325	0.0884	CrCbGaD
Zuclopenthixol—Agranulocytosis—Doxorubicin—kidney cancer	0.000324	0.000451	CcSEcCtD
Zuclopenthixol—Hypotension—Capecitabine—kidney cancer	0.000321	0.000447	CcSEcCtD
Zuclopenthixol—Trazodone—ABCB1—kidney cancer	0.00032	0.0869	CrCbGaD
Zuclopenthixol—Vomiting—Gemcitabine—kidney cancer	0.000318	0.000443	CcSEcCtD
Zuclopenthixol—Rash—Gemcitabine—kidney cancer	0.000315	0.000439	CcSEcCtD
Zuclopenthixol—Dermatitis—Gemcitabine—kidney cancer	0.000315	0.000438	CcSEcCtD
Zuclopenthixol—Headache—Gemcitabine—kidney cancer	0.000313	0.000436	CcSEcCtD
Zuclopenthixol—Nausea—Vincristine—kidney cancer	0.000313	0.000436	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000313	0.000436	CcSEcCtD
Zuclopenthixol—Insomnia—Capecitabine—kidney cancer	0.00031	0.000433	CcSEcCtD
Zuclopenthixol—Paraesthesia—Capecitabine—kidney cancer	0.000308	0.000429	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Paclitaxel—kidney cancer	0.000308	0.000429	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Doxorubicin—kidney cancer	0.000308	0.000428	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Doxorubicin—kidney cancer	0.000307	0.000427	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Doxorubicin—kidney cancer	0.000306	0.000426	CcSEcCtD
Zuclopenthixol—Dyspnoea—Capecitabine—kidney cancer	0.000306	0.000426	CcSEcCtD
Zuclopenthixol—Urethral disorder—Doxorubicin—kidney cancer	0.000305	0.000425	CcSEcCtD
Zuclopenthixol—Dyspepsia—Capecitabine—kidney cancer	0.000302	0.000421	CcSEcCtD
Zuclopenthixol—Visual impairment—Doxorubicin—kidney cancer	0.0003	0.000418	CcSEcCtD
Zuclopenthixol—Asthenia—Paclitaxel—kidney cancer	0.0003	0.000418	CcSEcCtD
Zuclopenthixol—Decreased appetite—Capecitabine—kidney cancer	0.000298	0.000416	CcSEcCtD
Zuclopenthixol—Nausea—Gemcitabine—kidney cancer	0.000297	0.000413	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000296	0.000413	CcSEcCtD
Zuclopenthixol—Fatigue—Capecitabine—kidney cancer	0.000296	0.000412	CcSEcCtD
Zuclopenthixol—Pruritus—Paclitaxel—kidney cancer	0.000296	0.000412	CcSEcCtD
Zuclopenthixol—Pain—Capecitabine—kidney cancer	0.000293	0.000409	CcSEcCtD
Zuclopenthixol—Constipation—Capecitabine—kidney cancer	0.000293	0.000409	CcSEcCtD
Zuclopenthixol—Eye disorder—Doxorubicin—kidney cancer	0.000291	0.000405	CcSEcCtD
Zuclopenthixol—Tinnitus—Doxorubicin—kidney cancer	0.00029	0.000405	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Doxorubicin—kidney cancer	0.000289	0.000403	CcSEcCtD
Zuclopenthixol—Diarrhoea—Paclitaxel—kidney cancer	0.000286	0.000399	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Capecitabine—kidney cancer	0.000283	0.000394	CcSEcCtD
Zuclopenthixol—Angiopathy—Doxorubicin—kidney cancer	0.000283	0.000394	CcSEcCtD
Zuclopenthixol—Immune system disorder—Doxorubicin—kidney cancer	0.000281	0.000392	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Capecitabine—kidney cancer	0.000281	0.000391	CcSEcCtD
Zuclopenthixol—Arrhythmia—Doxorubicin—kidney cancer	0.000278	0.000388	CcSEcCtD
Zuclopenthixol—Dizziness—Paclitaxel—kidney cancer	0.000277	0.000385	CcSEcCtD
Zuclopenthixol—Mental disorder—Doxorubicin—kidney cancer	0.000273	0.00038	CcSEcCtD
Zuclopenthixol—Abdominal pain—Capecitabine—kidney cancer	0.000271	0.000378	CcSEcCtD
Zuclopenthixol—Body temperature increased—Capecitabine—kidney cancer	0.000271	0.000378	CcSEcCtD
Zuclopenthixol—Erythema—Doxorubicin—kidney cancer	0.000271	0.000378	CcSEcCtD
Zuclopenthixol—Malnutrition—Doxorubicin—kidney cancer	0.000271	0.000378	CcSEcCtD
Zuclopenthixol—Flatulence—Doxorubicin—kidney cancer	0.000267	0.000372	CcSEcCtD
Zuclopenthixol—Tension—Doxorubicin—kidney cancer	0.000266	0.000371	CcSEcCtD
Zuclopenthixol—Vomiting—Paclitaxel—kidney cancer	0.000266	0.000371	CcSEcCtD
Zuclopenthixol—Rash—Paclitaxel—kidney cancer	0.000264	0.000367	CcSEcCtD
Zuclopenthixol—Dermatitis—Paclitaxel—kidney cancer	0.000263	0.000367	CcSEcCtD
Zuclopenthixol—Nervousness—Doxorubicin—kidney cancer	0.000263	0.000367	CcSEcCtD
Zuclopenthixol—Headache—Paclitaxel—kidney cancer	0.000262	0.000365	CcSEcCtD
Zuclopenthixol—Fluphenazine—ABCB1—kidney cancer	0.000259	0.0704	CrCbGaD
Zuclopenthixol—Vision blurred—Doxorubicin—kidney cancer	0.000255	0.000356	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Capecitabine—kidney cancer	0.000253	0.000352	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Doxorubicin—kidney cancer	0.000252	0.00035	CcSEcCtD
Zuclopenthixol—Agitation—Doxorubicin—kidney cancer	0.000249	0.000347	CcSEcCtD
Zuclopenthixol—Nausea—Paclitaxel—kidney cancer	0.000248	0.000346	CcSEcCtD
Zuclopenthixol—Asthenia—Capecitabine—kidney cancer	0.000246	0.000343	CcSEcCtD
Zuclopenthixol—Malaise—Doxorubicin—kidney cancer	0.000244	0.000341	CcSEcCtD
Zuclopenthixol—Vertigo—Doxorubicin—kidney cancer	0.000244	0.000339	CcSEcCtD
Zuclopenthixol—Syncope—Doxorubicin—kidney cancer	0.000243	0.000339	CcSEcCtD
Zuclopenthixol—Pruritus—Capecitabine—kidney cancer	0.000243	0.000338	CcSEcCtD
Zuclopenthixol—Leukopenia—Doxorubicin—kidney cancer	0.000243	0.000338	CcSEcCtD
Zuclopenthixol—Palpitations—Doxorubicin—kidney cancer	0.00024	0.000334	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Doxorubicin—kidney cancer	0.000238	0.000332	CcSEcCtD
Zuclopenthixol—Chlorprothixene—ABCB1—kidney cancer	0.000236	0.0641	CrCbGaD
Zuclopenthixol—Convulsion—Doxorubicin—kidney cancer	0.000235	0.000327	CcSEcCtD
Zuclopenthixol—Diarrhoea—Capecitabine—kidney cancer	0.000235	0.000327	CcSEcCtD
Zuclopenthixol—Hypertension—Doxorubicin—kidney cancer	0.000234	0.000326	CcSEcCtD
Zuclopenthixol—Myalgia—Doxorubicin—kidney cancer	0.000231	0.000322	CcSEcCtD
Zuclopenthixol—Anxiety—Doxorubicin—kidney cancer	0.00023	0.00032	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000229	0.000319	CcSEcCtD
Zuclopenthixol—Discomfort—Doxorubicin—kidney cancer	0.000228	0.000318	CcSEcCtD
Zuclopenthixol—Dizziness—Capecitabine—kidney cancer	0.000227	0.000316	CcSEcCtD
Zuclopenthixol—Dry mouth—Doxorubicin—kidney cancer	0.000226	0.000314	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Doxorubicin—kidney cancer	0.000221	0.000308	CcSEcCtD
Zuclopenthixol—Vomiting—Capecitabine—kidney cancer	0.000218	0.000304	CcSEcCtD
Zuclopenthixol—Shock—Doxorubicin—kidney cancer	0.000218	0.000303	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Doxorubicin—kidney cancer	0.000217	0.000302	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Doxorubicin—kidney cancer	0.000217	0.000302	CcSEcCtD
Zuclopenthixol—Rash—Capecitabine—kidney cancer	0.000216	0.000302	CcSEcCtD
Zuclopenthixol—Dermatitis—Capecitabine—kidney cancer	0.000216	0.000301	CcSEcCtD
Zuclopenthixol—Tachycardia—Doxorubicin—kidney cancer	0.000216	0.000301	CcSEcCtD
Zuclopenthixol—Headache—Capecitabine—kidney cancer	0.000215	0.0003	CcSEcCtD
Zuclopenthixol—Skin disorder—Doxorubicin—kidney cancer	0.000215	0.000299	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Doxorubicin—kidney cancer	0.000214	0.000298	CcSEcCtD
Zuclopenthixol—Anorexia—Doxorubicin—kidney cancer	0.000211	0.000294	CcSEcCtD
Zuclopenthixol—Trifluoperazine—ABCB1—kidney cancer	0.000207	0.0563	CrCbGaD
Zuclopenthixol—Hypotension—Doxorubicin—kidney cancer	0.000207	0.000288	CcSEcCtD
Zuclopenthixol—Nausea—Capecitabine—kidney cancer	0.000204	0.000284	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000202	0.000281	CcSEcCtD
Zuclopenthixol—Quetiapine—ABCB1—kidney cancer	0.000201	0.0546	CrCbGaD
Zuclopenthixol—Insomnia—Doxorubicin—kidney cancer	0.0002	0.000279	CcSEcCtD
Zuclopenthixol—Paraesthesia—Doxorubicin—kidney cancer	0.000199	0.000277	CcSEcCtD
Zuclopenthixol—Dyspnoea—Doxorubicin—kidney cancer	0.000197	0.000275	CcSEcCtD
Zuclopenthixol—Somnolence—Doxorubicin—kidney cancer	0.000197	0.000274	CcSEcCtD
Zuclopenthixol—Dyspepsia—Doxorubicin—kidney cancer	0.000195	0.000271	CcSEcCtD
Zuclopenthixol—Decreased appetite—Doxorubicin—kidney cancer	0.000192	0.000268	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000191	0.000266	CcSEcCtD
Zuclopenthixol—Fatigue—Doxorubicin—kidney cancer	0.000191	0.000266	CcSEcCtD
Zuclopenthixol—Constipation—Doxorubicin—kidney cancer	0.000189	0.000264	CcSEcCtD
Zuclopenthixol—Pain—Doxorubicin—kidney cancer	0.000189	0.000264	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Doxorubicin—kidney cancer	0.000182	0.000254	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000181	0.000252	CcSEcCtD
Zuclopenthixol—Abdominal pain—Doxorubicin—kidney cancer	0.000175	0.000244	CcSEcCtD
Zuclopenthixol—Body temperature increased—Doxorubicin—kidney cancer	0.000175	0.000244	CcSEcCtD
Zuclopenthixol—Clozapine—ABCB1—kidney cancer	0.000173	0.047	CrCbGaD
Zuclopenthixol—Hypersensitivity—Doxorubicin—kidney cancer	0.000163	0.000227	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ABCB1—kidney cancer	0.000162	0.0442	CrCbGaD
Zuclopenthixol—Asthenia—Doxorubicin—kidney cancer	0.000159	0.000221	CcSEcCtD
Zuclopenthixol—Pruritus—Doxorubicin—kidney cancer	0.000157	0.000218	CcSEcCtD
Zuclopenthixol—Diarrhoea—Doxorubicin—kidney cancer	0.000151	0.000211	CcSEcCtD
Zuclopenthixol—Dizziness—Doxorubicin—kidney cancer	0.000146	0.000204	CcSEcCtD
Zuclopenthixol—Vomiting—Doxorubicin—kidney cancer	0.000141	0.000196	CcSEcCtD
Zuclopenthixol—Rash—Doxorubicin—kidney cancer	0.000139	0.000194	CcSEcCtD
Zuclopenthixol—Dermatitis—Doxorubicin—kidney cancer	0.000139	0.000194	CcSEcCtD
Zuclopenthixol—Headache—Doxorubicin—kidney cancer	0.000139	0.000193	CcSEcCtD
Zuclopenthixol—Nausea—Doxorubicin—kidney cancer	0.000131	0.000183	CcSEcCtD
